Episode

Ep. 188: Red flags of treatable rare myopathies

Podcast
eanCast: Weekly Neurology
Published
Feb 15, 2026
Duration seconds
1973
Processing state
not_requested
Canonical source
https://eancast.podigee.io/188-neue-episode
Audio
https://audio.podigee-cdn.net/2353126-m-5e59e6ee3e0f953c61664ca6699c730a.mp3?source=feed
JSON
/v1/public/podcasts/eancast-weekly-neurology-5497158/episodes/ep-188-red-flags-of-treatable-rare-myopathies
Markdown
/podcast/eancast-weekly-neurology-5497158/ep-188-red-flags-of-treatable-rare-myopathies.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/eancast-weekly-neurology-5497158/episodes/ep-188-red-flags-of-treatable-rare-myopathies/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/eancast-weekly-neurology-5497158/ep-188-red-flags-of-treatable-rare-myopathies.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Moderator: Olimpia Musumeci (Messina, Italy) Guests: Antonio Toscano (Messina, Italy), Marianne De Visser (Amsterdam, Netherlands) In this episode, Olimpia Musumeci speaks with Antonio Toscano and Marianne de Visser about hereditary, particularly metabolic, and acquired myopathies, especially idiopathic inflammatory myopathies amenable to treatment. They review advances in pathophysiology, diagnostic approaches and novel therapies, highlighting clinical red flags and strategies that have a significant impact on timely diagnosis and management in daily neurological practice.